SCHEMBL4359037

SCHEMBL4359037

O=C(N[C@H](CO)Cc1ccccc1)[C@H](Cc1ccccc1)NCc1ccncc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.56
ROCK1 Q13464 4/20 0.56
MAPK1 P28482 3/20 0.56
RPS6KA5 O75582 2/20 0.56
RPS6KA4 O75676 2/20 0.56
PRKACA P17612 2/20 0.56
GSK3B P49841 2/20 0.56
PRKX P51817 2/20 0.56
PRKG1 Q13976 2/20 0.56
CLK4 Q9HAZ1 2/20 0.56
GSK3A P49840 1/20 0.56
IRAK1 P51617 1/20 0.56
PKN2 Q16513 1/20 0.56
SGK2 Q9HBY8 1/20 0.56
CYP3A4 P08684 2/20 0.54
ALDH1A1 P00352 1/20 0.51
PSMB5 P28074 2/20 0.51
GPR142 Q7Z601 4/20 0.51
LIMK1 P53667 1/20 0.49
MEP1B Q16820 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4359846 0.94 ROCK2 (0.51) ROCK2ROCK1MAPK1RPS6KA5RPS6KA4
SCHEMBL4367262 0.82 ROCK2 (0.70) ROCK2ROCK1MAPK1RPS6KA5RPS6KA4
SCHEMBL4364469 0.81 ATM (0.60) CYP3A4ALDH1A1PSMB5GPR142MMP9
SCHEMBL29788288 0.81 ALDH1A1 (0.57) CYP3A4ALDH1A1PSMB5GPR142MEP1B
SCHEMBL4356211 0.81 MME (0.58) CYP3A4ALDH1A1PSMB5GPR142
SCHEMBL4359110 0.77 TSHR (0.58) CYP3A4ALDH1A1PSMB5GPR142
SCHEMBL4363988 0.77 TSHR (0.58) CYP3A4ALDH1A1PSMB5GPR142
SCHEMBL6192681 0.76 ROCK2 (0.59) ROCK2ROCK1MAPK1RPS6KA5RPS6KA4
SCHEMBL3134757 0.76 CYP3A4 (0.67) MAPK1CYP3A4ALDH1A1
SCHEMBL6092542 0.76 ROCK2 (0.80) ROCK2ROCK1MAPK1RPS6KA5RPS6KA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) 2009-10-01 US claimed
US-9023809-B2 Phenylalanine dipeptide derivatives, compositions and use thereof THE KEY LABORATORY OF CHEMISTRY FOR NATURAL PRODUCTS OF GUIZHOU PROVINCE AND CHINESE ACADEMY OF SCIENCES (CN) 2015-05-05 US disclosed
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247470-A1 PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF DNPEP, PEPD, VIP ROCK2 4037/4885ROCK1 2859/4885MAPK1 2260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.